Radiodermatitis Market Size SWOT analysis and Key Business Strategies, Demand & Forecast - 2031 | Intermed Pharmaceuticals, Mölnlycke Health Care

Market Overview:

Radiodermatitis refers to skin damage or irritation caused by radiation therapy. It is a common side effect of radiotherapy treatment for cancer patients. Products used in prevention and treatment of radiodermatitis include topical agents, dressings, and skin care products.

Market Dynamics:

The global radiodermatitis market is expected to witness significant growth owing to increasing incidence of cancer and rising use of radiotherapy for cancer treatment. According to WHO, cancer burden rose to 19.3 million new cases and 10.0 million cancer deaths in 2020 worldwide. Moreover, around 50% of all cancer patients receive radiotherapy as part of their cancer treatment. Technological advancements in radiotherapy techniques such as IMRT and IGRT have further raised the use of radiotherapy for cancer. This is expected to drive the demand for preventive and treatment products for radiodermatitis over the forecast period. Additionally, growing awareness about management of radiodermatitis and availability of new topical agents and dressings are further anticipated to propel the market growth.

Request Sample Copy of the Report at: - https://www.coherentmarketinsights.com/insight/request-sample/3881

List of TOP Players in Market Report are: -

◘ Acelity Inc. (3M)BMG Pharma S.r.l.
◘ ConvaTec Group PLC
◘ DermaSciences Inc. (Integra LifeSciences Holdings Corporation)
◘ Intermed Pharmaceuticals
◘ Mölnlycke Health Care
◘ Smith & Nephew Plc
◘ Stratpharma AG
◘ Kannalife Inc.
◘ McKesson Corporation.

Market Drivers:

Increasing incidences of cancer leading to rising radiotherapy procedures

The market for radiodermatitis treatment is primarily driven by the rising incidences of different types of cancer worldwide. Radiotherapy is one of the most common treatment procedures used for managing cancer. According to the World Health Organization (WHO), cancer is one of the leading causes of death globally, accounting for nearly 10 million deaths in 2020. Furthermore, the National Cancer Institute estimates that in the US, there will be over 1.9 million new cancer cases diagnosed and over 609,000 cancer deaths in 2022. With the increasing prevalence of various cancers, the demand for radiotherapy as a treatment option is also increasing significantly. Radiotherapy finds application in nearly 50-60% of all cancer cases. Higher exposure to radiation during radiotherapy can often lead to radiodermatitis. Therefore, growing adoption of radiotherapy for cancer management is directly leading to subsequent rise in cases of radiodermatitis, thus augmenting the market growth.

Increasing R&D investments and new product launches

Pharmaceutical manufacturers are increasingly investing in R&D activities to develop new and more effective treatment options for radiodermatitis. There is also a rise in new product launches catering to different grades of radiodermatitis. For instance, in March 2022, Dermadex received FDA approval for Dermadex hydrogel patches for grade 1 and 2 radiodermatitis. In July 2021, Mölnlycke Health Care launched SafERGEL for preventing and treating radiation-induced skin reactions. Numerous other companies are also engaged in developing topical agents, dressings, and other treatment modalities. Rising investment in R&D and continuous product innovation are helping expand the available treatment options and driving the overall market growth.

Market Restrain:

Lack of awareness about preventive measures

One of the key factors restraining the growth of the radiodermatitis market is lack of adequate awareness regarding preventive measures that can be taken prior to and during radiation therapy. Many patients undergoing radiotherapy are unaware of simple steps like use of moisturizers, staying hydrated, and avoiding hot showers that can help protect the skin against radiation damage. Limited health literacy also restricts access to credible information sources. This leads to delayed diagnosis and treatment-seeking behavior. As a result, many cases progress to more advanced stages requiring costly interventions like debridement and skin grafts. Creating widespread awareness through patient education programs can help address this issue to some extent by encouraging preventive practices and early treatment. However, lack of awareness still persists significantly, especially in developing nations, negatively impacting the market.

Buy This Premium Report and Get Upto 25 % OFF: https://www.coherentmarketinsights.com/insight/buy-now/3881

Market Opportunity:

Innovative product development strategies

Product innovations and extensive R&D focused on developing more effective and reliable treatment options provide lucrative opportunities for growth in the radiodermatitis market. With the increasing need for advanced wound care products, manufacturers have an opportunity to invest in developing novel formulations, controlled delivery mechanisms, and specialized dressings catering to different grades of radiodermatitis. Furthermore, integrating technologies like silver, honey, and microneedling in product design can enhance therapeutic effectiveness. Development of cheaper generic drugs and affordable dressings also opens up opportunities in price-sensitive developing markets. Adopting innovative strategies focused on combining wound healing agents, anti-inflammatory drugs, protective barriers, and antimicrobials can lead to launches of premium products with improved clinical outcomes. This will attract more patients and boost overall revenues. Moreover, collaborating with healthcare providers for clinical research aids new product commercialization, creating a win-win for manufacturers and patients.

Market Trends:

Rise in inclination towards homecare setting

There is a notable trend observed where patients are increasingly opting for homecare setting over costly hospital visits for minor wound management. This could partly be attributed to the COVID-19 pandemic that emphasized the need for social distancing, remote monitoring, and cost-effectiveness. With advancements in connected health solutions, tools enabling remote consultation, virtual dressing changes, and monitoring of treatment progress at home have become available. Furthermore, availability of user-friendly topical creams, hydrogels, and dressings suitable for self-administration make homecare a viable option.

Market Detailed Segmentation:

By Product Type:

Topical Agents
Corticosteroids
Hydrophilic Creams
Others
Oral Medication
Corticosteroids
Other
Analgesic & Anti-Inflammatory
Dressing
Hydrogel, Hydrocolloid
No Sting Barrier Film
Honey Impregnated Dressing
Silicone coated Dressing
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Furthermore, the years considered for the study are as follows:

Historical data - 2016-2022
The base year for estimation - is 2022
Estimated Year - 2024
Forecast period** - 2024 to 2031

This Radiodermatitis Market Research/Analysis Report Contains Answers to your following Questions:

◈What are the current global trends in the Radiodermatitis market, and will the market experience an increase or decrease in demand in the upcoming years?

◈ What is the expected demand for various product types within the Radiodermatitis market, and what are the emerging Market applications and trends?

◈ What are the projections for the global Radiodermatitis Market in terms of capacity, production, production value, cost, profit, market share, supply, consumption, import, and export?

◈ How will strategic developments shape the Market trajectory in the medium to long term?

◈ What factors contribute to the final price of Radiodermatitis , and what are the raw materials used in its manufacturing?

◈ What is the market's growth potential, particularly with the increasing adoption of Radiodermatitis in mining?

◈ What is the current and 2022 value of the global market, and who are the leading companies in this market?

◈ What recent Market trends can be leveraged to create additional revenue streams?

◈ What entry strategies, economic impact mitigation measures, and marketing channels should be considered for the Radiodermatitis Market?

We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/3881

Summarized Extracts from TOC of Market Study

Chapter 1 Radiodermatitis Introduction and Market Overview

1.1 Objectives of the Study

1.2 Overview of Radiodermatitis

1.3 Scope of The Study

1.3.1 Key Market Segments

1.3.2 Players Covered

1.3.3 COVID-19's impact on the Radiodermatitis industry

1.4 Methodology of The Study

1.5 Research Data Source

Chapter 2 Executive Summary

Chapter 3 Industry Chain Analysis

Chapter 4 Market, by Type

Chapter 5 Market, by Application

Chapter 6 Market Analysis by Regions

Chapter 7 North America Market Analysis by Countries

Chapter 8 Europe Radiodermatitis Market Analysis by Countries

Chapter 9 Asia Pacific Radiodermatitis Market Analysis by Countries

Chapter 10 Middle East and Africa Radiodermatitis Market Analysis by Countries

Chapter 11 South America Radiodermatitis Market Analysis by Countries

Chapter 12 Competitive Landscape

Chapter 13 Industry Outlook

Chapter 14 Market Forecast

Chapter 15 New Project Feasibility Analysis

Contact Us

Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States
Phone: US +12067016702 / UK +4402081334027
JAPAN:+81-50-5539-1737
INDIA:+91-848-285-0837
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.